SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.07-0.1%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Lamb who wrote (4330)7/14/1998 5:10:00 PM
From: BiGx  Read Replies (1) of 9523
 
I don't see PFE moving up more than 10% before Q3 earnings are announced in October unless:

1- Viagra is approved in several major markets overseas or,
2- Zeldox is approved or,
3- A special stockholder meeting is announced to vote on authorizing additional shares or,
4- A surprise positive announcement at the 7/24 analyst meeting

There are too many analysts expressing concern about the high P/E (regardless of whether or not it is justified) and there is still uneasiness about Viagra (safety). So, institutional buyers will not push it up and the price is too steep for enough small investors to bid it up.

I do see big growth once good Q3 numbers are in (with continued solid Viagra numbers as well as growth with Trovan and the rest of the portfolio).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News